NCT04065880View on ClinicalTrials.gov

Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

July 1, 2021

Study Completion Date

July 31, 2021

Conditions
Prolonged Air LeakPostoperative Air Leak
Interventions
OTHER

TachoSil®

topical absorbable fibrin sealant patch applied directly on the lung area with air fistula.

OTHER

Neoveil®

bioabsorbable soft-tissue reinforcement material applied on the normal shape of the lung at the end of the operation.

Trial Locations (1)

4031

Department of Thoracic Surgery, University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT04065880 - Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation | Biotech Hunter | Biotech Hunter